Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST| APTARGROUP, Inc. (NYSE: ATR) | Delayed: 126.75 +0.20 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.55 | 52 Week High | $81.50 | |||
| Open | $126.77 | 52 Week Low | $66.33 | |||
| Day High | $127.68 | P/E | 50.30 | |||
| Day Low | $126.71 | EPS | $2.52 | |||
| Volume | 28,751 | |||||
| (NASDAQ: MIST) | Delayed: 0.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.65 | 52 Week High | $ | |||
| Open | $0.65 | 52 Week Low | $ | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.64 | EPS | $ | |||
| Volume | 310,063 | |||||



